Continuous Data Monitoring and AI-assisted Predictive Medicine “better” for Diabetes Care, Says Clinic

Continuous Data Monitoring and AI-assisted Predictive Medicine “better” for Diabetes Care, Says Clinic

Posted Oct 20, 2021 from

The Dubai-based GluCare Integrated Diabetes Center has published a second set of clinical results revealing further reduction of haemoglobin A1c (HbA1c) levels in its patients.

Remote continuous data monitoring – a personalised, tech-focused approach to diabetes management employed by one Dubai-based specialist clinic – continues to demonstrate positive results in its patients, it has been confirmed.

Six months since the release of its first report showcasing preliminary outcomes of its care model, GluCare Integrated Diabetes Center has now published a second set of clinical results revealing further reduction of haemoglobin A1c (HbA1c) levels in its patients.

Appearing in the journal Diabetes Management, the clinic’s latest results show that those undergoing treatment reduced their HbA1c levels by an average of 2.14% over 90 days.

In April, results showed an average HbA1c reduction of 1.7%.


See Topics

See Also

Next Article